Transfusion in surgery and trauma

Critical Care Clinics

Volumn 20, Issue 2, 2004, Pages 281-297

  Schulman, Carl I ^a   Cohn, Stephen M ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; APROTININ; BLOOD SUBSTITUTE; DESMOPRESSIN; ERYTHROPOIETIN; FIBRIN GLUE; FLUOROCARBON; GERMALL 115; HEMOGLOBIN; HEMOSOL; INTERLEUKIN 10; POLYMERIZED HEMOGLOBIN; RECOMBINANT ERYTHROPOIETIN; SEALANT; TRANEXAMIC ACID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACIDOSIS; ALLOIMMUNIZATION; ALLOTRANSPLANTATION; ANEMIA; BLOOD AUTOTRANSFUSION; BLOOD CLOTTING DISORDER; BLOOD STORAGE; BLOOD TRANSFUSION; BLOOD VOLUME; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; CRITICAL ILLNESS; DRUG COST; ELECTIVE SURGERY; EMERGENCY SURGERY; HEART SURGERY; HEMODILUTION; HUMAN; HYPOTHERMIA; HYPOXEMIA; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INJURY; INTENSIVE CARE; INTRAOPERATIVE PERIOD; ISCHEMIA; META ANALYSIS; ORTHOPEDIC SURGERY; POSTOPERATIVE INFECTION; PREOPERATIVE CARE; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; VASCULARIZATION;

BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HUMANS; SURGICAL PROCEDURES, OPERATIVE; WOUNDS AND INJURIES;

EID: 2342544102     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2003.12.005     Document Type: Review

References (71)

1. Beal R.W. The rational use of blood. Aust NZ J Surg. 46(4):1976;309-313
2. History of blood transfusion medicine. Available at: http://www. bloodbook.com/trans-history.html. Accessed: February 16, 2004
3. Starr D. Blood: an epic history of medicine and commerce. 1st edition:1999;Alfred A. Knopf, New York
4. National blood data resource center. Available at: http://www.nbdrc.org. Accessed: February 16, 2004
5. Groeger J.S., et al. Descriptive analysis of critical care units in the United States: patient characteristics and intensive care unit utilization. Crit Care Med. 21(2):1993;279-291
6. Corwin H.L., Parsonnet K.C., Gettinger A. RBC transfusion in the ICU. Is there a reason? Chest. 108(3):1995;767-771
7. Vincent J.L., et al. Anemia and blood transfusion in critically ill patients. JAMA. 288(12):2002;1499-1507
8. Adams R.C., Lundy J.S. Anesthesia in cases of poor risk. Some suggestions for decreasing the risk. Surg Gynecol Obstet. 74:1942;1011
9. Hébert P.C., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion requirements in critical care investigators, Canadian Critical Care Trials Group. N Engl J Med. 340(6):1999;409-417
10. Consensus conference. Perioperative red blood cell transfusion. JAMA. 260(18):1988;2700-2703
11. Carson J.L., et al. A pilot randomized trial comparing symptomatic vs. hemoglobin-level-driven red blood cell transfusions following hip fracture. Transfusion. 38(6):1998;522-529
12. Hogue C.W. Jr., Goodnough L.T., Monk T.G. Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy. Transfusion. 38(10):1998;924-931
13. Sauaia A., et al. Epidemiology of trauma deaths: a reassessment. J Trauma. 38(2):1995;185-193
14. Gubler K.D., et al. The impact of hypothermia on dilutional coagulopathy. J Trauma. 36(6):1994;847-851
15. Orlinsky M., et al. Current controversies in shock and resuscitation. Surg Clin North Am. 81(6):2001;1217-1262. xi-xii
16. Donaldson M.D., Seaman M.J., Park G.R. Massive blood transfusion. Br J Anaesth. 69(6):1992;621-630
17. Faringer P.D., et al. Blood component supplementation during massive transfusion of AS-1 red cells in trauma patients. J Trauma. 34(4):1993;481-485. discussion: 485-7
18. Dennis J. Blood replacement, massive transfusion, and hemostasis in hemorrhagic shock. Trauma Q. 8:1992;62-68
19. Whitten C.S., Giesecke A.H., et al. An analysis of survival in patients with traumatic injuries who received transfusions of forty units or more. Anesthesiology. 83:1995;A218
20. Knottenbelt J.D. Low initial hemoglobin levels in trauma patients: an important indicator of ongoing hemorrhage. J Trauma. 31(10):1991;1396-1399
21. Miller S.E., Lim R.C., Pearl T.C.Y., et al. Massive blood transfusion in trauma patients: a study of factors effecting survival. J Trauma. 22:1982;630
22. Farion K.J., et al. Changes in red cell transfusion practice among adult trauma victims. J Trauma. 44(4):1998;583-587
23. Koval K.J., et al. Does blood transfusion increase the risk of infection after hip fracture? J Orthop Trauma. 11(4):1997;260-265. discussion: 265-6
24. Houbiers J.G., et al. Transfusion of red cells is associated with increased incidence of bacterial infection after colorectal surgery: a prospective study. Transfusion. 37(2):1997;126-134
25. Biedler A.E., et al. Impact of alloantigens and storage-associated factors on stimulated cytokine response in an in vitro model of blood transfusion. Anesthesiology. 97(5):2002;1102-1109
26. Landers D.F., Dullye K.K. Vascular access and fluid resuscitation in trauma: issues of blood and blood products. Anesth Clin N Am. 17(1):1999;125-140
27. Fransen E., et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest. 116(5):1999;1233-1239
28. Sauaia A., et al. Early predictors of postinjury multiple organ failure. Arch Surg. 129(1):1994;39-45
29. Corwin H.L., Gettinger A., Pearl R.G., et al. The CRIT study: anemia and blood transfusion in the critically ill - current clinical practice in the United States. Crit Care Med. 32(1):2004;39-52
30. Fitzgerald R.D., et al. Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Crit Care Med. 25(5):1997;726-732
31. Sielenkamper A, White M, Martin C.M, Sibbald W.J, Chin-Yee I. Diaspirin crosslinked hemoglobin (DCLHb) increases oxygen uptake in septic, oxygen supply-dependent rats. 1996: American Thoracic Society 1996 International Conference.
32. Marik P.E., Sibbald W.J. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. JAMA. 269(23):1993;3024-3029
33. Silverman H.J., Tuma P. Gastric tonometry in patients with sepsis. Effects of dobutamine infusions and packed red blood cell transfusions. Chest. 102(1):1992;184-188
34. Martin C.M., Lu X., Hebert P., Schweitzer I. Age of transfused red blood cells is associated with ICU length of stay. Clin Invest Med. 17:1994;124
35. Purdy F.R., Tweeddale M.G., Merrick P.M. Association of mortality with age of blood transfused in septic ICU patients. Can J Anaesth. 44(12):1997;1256-1261
36. Vamvakas E.C., Carven J.H. Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells. Transfusion. 39(7):1999;701-710
37. Zallen G., et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg. 178(6):1999;570-572
38. Schulman C.I., et al. Impact of age of transfused blood in the trauma patient. J Trauma. 52(6):2002;1224-1225
39. O'Leary P.J. The physiologic basis of surgery. 1993;Williams & Wilkins, Philadelphia
40. Corwin H.L., Surgenor S.D., Gettinger A. Transfusion practice in the critically ill. Crit Care Med. 31(12):2003;S668-S671
41. Corwin H.L., et al. Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial. JAMA. 288(22):2002;2827-2835
42. Hutchinson A.B., et al. Utilization of technologies to reduce allogeneic blood transfusion in the United States. Transfus Med. 11(2):2001;79-85
43. Goldberg M.A. Perioperative epoetin alfa increases red blood cell mass and reduces exposure to transfusions: results of randomized clinical trials. Semin Hematol. 34(3 Suppl 2):1997;41-47
44. Laupacis A., Fergusson D. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Peri-operative Transfusion (ISPOT) Investigators. Transfus Med. 8(4):1998;309-317
45. Gould S.A., et al. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg. 187(2):1998;113-120. discussion: 120-2
46. LaMuraglia G.M., et al. The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg. 31(2):2000;299-308
47. Levy J.H., et al. Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial. J Thorac Cardiovasc Surg. 124(1):2002;35-42
48. Cheng D.C. Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery. Can J Anaesth. 48(4 Suppl):2001;S41-S48
49. Goodnough L.T., Monk T.G., Brecher M.E. Autologous blood procurement in the surgical setting: lessons learned in the last 10 years. Vox Sang. 71(3):1996;133-141
50. Toy P.T., et al. Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med. 316(9):1987;517-520
51. Renner S.W., Howanitz P.J., Bachner P. Preoperative autologous blood donation in 612 hospitals. A College of American Pathologists' Q-Probes study of quality issues in transfusion practice. Arch Pathol Lab Med. 116(6):1992;613-619
52. Blum L.N., et al. Crossover use of donated blood for autologous transfusion: report of the Council on Scientific Affairs, American Medical Association. Transfusion. 38(9):1998;891-895
53. Goodnough L.T., et al. Transfusion medicine. Second of two parts-blood conservation. N Engl J Med. 340(7):1999;525-533
54. Cohen J.A., Brecher M.E. Preoperative autologous blood donation: benefit or detriment? A mathematical analysis. Transfusion. 35(8):1995;640-644
55. Napier J.A., et al. Guidelines for autologous transfusion. II. Perioperative haemodilution and cell salvage. British Committee for Standards in Haematology Blood Transfusion Task Force. Autologous Transfusion Working Party. Br J Anaesth. 78(6):1997;768-771
56. Brecher M.E., Rosenfeld M. Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion. 34(2):1994;176-179
57. Monk T.G., et al. Acute normovolemic hemodilution can replace preoperative autologous blood donation as a standard of care for autologous blood procurement in radical prostatectomy. Anesth Analg. 85(5):1997;953-958
58. Schmied H., et al. The effects of red-cell scavenging, hemodilution, and active warming on allogenic blood requirements in patients undergoing hip or knee arthroplasty. Anesth Analg. 86(2):1998;387-391
59. Bryson G.L., Laupacis A., Wells G.A. Does acute normovolemic hemodilution reduce perioperative allogeneic transfusion? A meta-analysis. The International Study of Perioperative Transfusion. Anesth Analg. 86(1):1998;9-15
60. Goodnough L.T., et al. A randomized trial of acute normovolemic hemodilution compared to preoperative autologous blood donation in total knee arthroplasty. Vox Sang. 77(1):1999;11-16
61. Graham I.D., et al. The use of technologies to minimize exposure to perioperative allogeneic blood transfusion in elective surgery. A survey of Canadian hospitals. Int J Technol Assess Health Care. 16(1):2000;228-241
62. Williamson K.R., Taswell H.F. Intraoperative blood salvage: a review. Transfusion. 31(7):1991;662-675
63. Timberlake G.A., McSwain N.E. Jr. Autotransfusion of blood contaminated by enteric contents: a potentially life-saving measure in the massively hemorrhaging trauma patient? J Trauma. 28(6):1988;855-857
64. Clagett G.P., et al. A randomized trial of intraoperative autotransfusion during aortic surgery. J Vasc Surg. 29(1):1999;22-30. discussion: 30-1
65. Smith L.A., Barker D.E., Burns R.P. Autotransfusion utilization in abdominal trauma. Am Surg. 63(1):1997;47-49
66. Nervi C., et al. A multicenter clinical trial to evaluate the topical hemostatic efficacy of fibrin sealant in burn patients. J Burn Care Rehabil. 22(2):2001;99-103
67. Carless P.A., Anthony D.M., Henry D.A. Systematic review of the use of fibrin sealant to minimize perioperative allogeneic blood transfusion. Br J Surg. 89(6):2002;695-703
68. Lopez P.P., Rashid Q.N., Cohn S.M. Chapter 33: Fibrin glue use in surgery. Lewandrowski K., Wise D.L., Trantolo D.J., Gresser J.D., Yaszemski M.J., Altobelli D.E. Tissue engineering and biodegradable equivalents: scientific and clinical applications. 2002;665-680 Marcel Dekker Inc. New York
69. Katz E., et al. The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel. Isr Med Assoc J. 3(11):2001;809-812
70. Proposito D., et al. [Objectives of a bloodless surgery program. A comparative study (major surgery vs. minor-medium surgery) in 51 Jehova's Witnesses patients]. Ann Ital Chir. 73(2):2002;197-209. discussion: 209-10
71. Mitchell D. Annual report: Center for Bloodless Medicine & Surgery at the University of Miami/Jackson Memorial Medical Center. 2001;University of Miami, Miami, FL